BioPharma Dive18d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Commonwealth Fund8d
Drug Costs and Their Impact on Care: Insights from Medicare Patients and Providers
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
First nonopioid painkiller in 25 years approved by FDA, offering new hope for patients
A newly approved pain medication, suzetrigine, is the first nonopioid analgesic in 25 years to receive clearance from the U.S ...
STAT23d
Veru says its drug preserved lean mass in patients taking Wegovy
Veru said Monday that its investigational drug helped preserve lean mass in patients taking the obesity treatment Wegovy, though some experts were skeptical that the topline results were adequate ...
Reuters23d
Akero soars as drug shows it reverses scarring in liver disease patients
Jan 27 (Reuters) - Akero Therapeutics (AKRO.O), opens new tab shares gained 117% in early trading on Monday, after its lead drug showed it can help patients with a type of liver disease to reverse ...
STAT23d
Akero drug reverses liver scarring in study of severe MASH patients
Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...
Medscape23d
Three Tips to Help Your US Patients Manage Their Drug Costs
But patients increasingly are confronting both rising drug prices and skimpier medical benefits. Clinicians are likely to hear more from patients right now, as deductibles and copays reset for the ...